Treatabolome presentations now online

Within the European Solve-RD project, we participate in work to create a “treatabolome” – a database of evidence for treatments for rare disorders linked to the precise genetic defect. Many rare diseases do have treatments available, but frequently there is a substantial delay before patients affected by the disease receive the right treatment. By making this information more readily accessible to clinicians at the time of diagnosis, the treatabolome initiative aims to reduce this treatment delay.

Solve-RD held a treatabolome workshop at ESHG 2020, the aim of which was to show interested clinicians and researchers how to participate in this initiative and create a treatabolome for their own diseases of interest. We are delighted that we are now able to make the presentations available here on the Lochmüller Lab website and we encourage anyone who would like to participate to contact Antonio Atalaia from the Institut de Myologie in Paris, France. Systematic reviews of treatments for neuromuscular diseases may be submitted for a special issue of the Journal of Neuromuscular Diseases, but the concept can be used for any rare disease where treatments are available.

Please view the presentations below and get in touch if you’re interested!

Presentation 1 – Antonio Atalaia – introduction

Presentation 2 – Gisèle Bonne – treatabolome concept

Presentation 3 – Rachel Thompson – systematic reviews

Presentation 4 – Leslie Matalonga – treatabolome database

treatabolome-presentations

Read next...

Sally describes lab research to FSHD visitors

Lochmüller Lab hosts information session on clinical research for FSHD

On Saturday June 11th we were delighted to welcome individuals and families living with facioscapulohumeral muscular dystrophy (FSHD) and members of the FSHD Society to...
JND-cover

May 2022 Issue of the Journal of Neuromuscular Diseases Available Online

The Lochmüller Lab is pleased to share that the the Journal of Neuromuscular Diseases has published its third issue of 2022! In Volume 9, Issue...
CHEO

CHEO Registers Tenth Patient in AMO Reach CDM Clinical Trial

The Lochmüller Lab is excited to share that as of March 14, 2022 our site at the Children’s Hospital of Eastern Ontario (CHEO) has registered...
CNDR_logo-2x3

Canadian Neuromuscular Disease Registry Launches New Congenital Myasthenic Syndrome Registry

We’re delighted to announce that a new registry for patients with congenital myasthenic syndrome (CMS) has just been launched within the Canadian Neuromuscular Disease Registry (CNDR).  This...
Lochmuller Lab at the Rideau Canal, group picture.

Lochmüller Lab Visits World’s Longest Skating Rink

This February the Lochmüller Lab took a break from the research benches at the CHEO RI to visit the Rideau Canal Skateway. A UNESCO world...
JND_V9-i1

January 2022 Issue of the Journal of Neuromuscular Diseases Available Online

The Lochmüller Lab is pleased to share that the the Journal of Neuromuscular Diseases has published its first issue of 2022! In Volume 9, Issue...